Latest

Parkinson’s disease

This shows a person sitting and mushrooms.

·April 30, 2025·6 min read

Psilocybin Shows Promise for Parkinson’s Mood and Motor Symptoms

A new pilot study reveals that psilocybin—the compound found in psychedelic mushrooms—may significantly improve mood, cognition, and motor function in people with Parkinson’s disease. The compound was well tolerated, with only mild side effects, and benefits persisted for weeks after dosing. While the study was primarily designed to test safety, researchers observed meaningful and lasting improvements in multiple symptoms.

Featured Neuroscience

·April 29, 2025·7 min read

Brain’s Switching Mechanism Revealed: How We Rapidly Change Actions

New research shows that switching between actions is not simply stopping and starting again, but a unique brain mechanism that suppresses the previous action to initiate a new one. Using computational models, behavioral tasks, and clinical data from Parkinson’s patients, researchers found that stopping and switching are distinct cognitive motor processes.

Featured Genetics Neurology Neuroscience

·April 27, 2025·4 min read

New Biomarker Enables Early, Accurate Diagnosis of Parkinson’s

Researchers have identified a biomarker in spinal fluid that can detect Parkinson’s disease in its early stages with over 90% accuracy. Using a patented immuno-infrared sensor (iRS) technology, they measured the misfolding of the alpha-synuclein (αSyn) protein, a key driver of the disease.

Featured Neurology Neuroscience

·April 16, 2025·5 min read

AI Tool Predicts Toxic Protein Structures Behind Brain Disorders

A new AI tool called RibbonFold is revolutionizing how scientists understand misfolded proteins linked to Alzheimer’s and Parkinson’s. Unlike existing tools such as AlphaFold, which predict correctly folded proteins, RibbonFold is specifically designed to model the twisted, ribbonlike shapes of amyloid fibrils that accumulate in neurodegenerative diseases.

Brain Cancer Featured Genetics Neurology Neuroscience

·April 14, 2025·4 min read

Shared Protein Link Found Between Parkinson’s and Cancer

A new study reveals that the protein alpha-synuclein, known for its role in Parkinson’s disease, also contributes to the development of melanoma by promoting excessive DNA repair and cell proliferation. While in neurons, excess alpha-synuclein leads to cell death, in melanoma cells it enables uncontrolled growth by recruiting repair proteins to DNA breaks.

Featured Genetics Neuroscience

·April 12, 2025·5 min read

New Genes Linked to Parkinson’s Risk Revealed

Researchers have long wondered why some people with high-risk Parkinson’s gene variants develop the disease while others don’t. A new study has uncovered that additional genetic players, particularly the Commander gene complex, influence whether the disease manifests.

Autism Featured Genetics Neurology Neuroscience

·March 7, 2025·4 min read

Genetic Variant in ITSN1 Linked to Higher Parkinson’s and ASD Risk

A new study has identified genetic variants in the ITSN1 gene that significantly increase the risk of developing Parkinson’s disease. Researchers analyzed nearly 500,000 genetic profiles and found that individuals carrying ITSN1 variants face up to a tenfold higher risk of Parkinson’s.

Featured Neurology Neuroscience

·February 25, 2025·4 min read

FDA Approves Adaptive DBS for Parkinson’s Patients

The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms. Unlike traditional DBS, which delivers constant stimulation, aDBS monitors brain activity and responds with precise electric pulses to prevent stiffness and involuntary movements.

Auditory Neuroscience Featured Neurology Neuroscience

·January 14, 2025·5 min read

Hearing Loss May Signal Increased Risk of Parkinson’s Disease

A new study has identified a potential link between hearing impairment and an increased risk of developing Parkinson’s disease. Researchers analyzed data from over 159,000 individuals, finding that every 10-decibel increase in hearing loss corresponded to a 57% higher risk of Parkinson’s.

Featured Neurology Neuroscience

·January 3, 2025·5 min read

Ketamine Offers Hope for Parkinson’s Treatment-Linked Dyskinesia

Researchers have uncovered a new understanding of levodopa-induced dyskinesia, a common side effect in Parkinson’s patients, revealing that the motor cortex disconnects rather than directly causing these movements.

Featured Neurology Neuroscience

·December 16, 2024·4 min read

Accurate Parkinson’s Detection via Emotional Brain Responses

A new study has achieved near-perfect accuracy in detecting Parkinson's disease by analyzing brain responses to emotional stimuli using EEG and AI. Researchers found that Parkinson's patients process emotions differently, struggling with recognizing fear, disgust, and surprise and focusing more on emotional intensity than valence.

This shows chemical imaging of the microbiome.

Featured Neurology Neuroscience

·November 21, 2024·5 min read

Parkinson’s Medication Alters Microbiome, Induces Iron Deficiency

The Parkinson's drug entacapone disrupts the gut microbiome by inducing iron deficiency, favoring the growth of potentially harmful bacteria like E. coli. Using advanced molecular techniques, researchers identified that entacapone interferes with iron availability, a critical resource for many gut microbes.

1 2 3 4 … 74

Parkinson’s disease

Psilocybin Shows Promise for Parkinson’s Mood and Motor Symptoms

Brain’s Switching Mechanism Revealed: How We Rapidly Change Actions

New Biomarker Enables Early, Accurate Diagnosis of Parkinson’s

AI Tool Predicts Toxic Protein Structures Behind Brain Disorders

Shared Protein Link Found Between Parkinson’s and Cancer

New Genes Linked to Parkinson’s Risk Revealed

Genetic Variant in ITSN1 Linked to Higher Parkinson’s and ASD Risk

FDA Approves Adaptive DBS for Parkinson’s Patients

Hearing Loss May Signal Increased Risk of Parkinson’s Disease

Ketamine Offers Hope for Parkinson’s Treatment-Linked Dyskinesia

Accurate Parkinson’s Detection via Emotional Brain Responses

Parkinson’s Medication Alters Microbiome, Induces Iron Deficiency

AI Tool Flags Predatory Journals, Building a Firewall for Science

Genetics Reveal How Human Contact Shapes Language Evolution

Most Autistic Adults Over 40 Remain Undiagnosed

“Junk DNA” Plays Key Role in Brain Development and Disease

Subscribe